Shopping Cart 0
Cart Subtotal
USD 0

Derma Sciences Inc (DSCI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Derma Sciences Inc (Derma Sciences) is a medical devices company. It focuses on advanced wound care and traditional wound care. Its advanced wound care product portfolio includes dermagran, silverseal, alginate dressing, aquasite hydrogel, primacol hydrocolloid, hydrocell foam and primaderm wound cleanser. The company's traditional wound care products include sponges; wound dressings; packing; island and barrier border gauze; non-adherent impregnated; conforming bandages; elastic net dressings; compression bandages; protective products; tapes and laparotomy sponges. It offers solutions to acute care, extended care, home health care, wound and burn care clinics and physician offices. Derma Science markets its products through direct sales force in the US and Canada. In foreign markets, its products are marketed through various licensing and distribution agreements. It has offices, manufacturing and distribution facilities in Missouri and Texas in the US, Canada, the UK and China. Derma Sciences is headquartered in Princeton, New Jersey, the US.

Derma Sciences Inc (DSCI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Derma Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Derma Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Derma Sciences Acquires MEDIHONEY from Comvita 11

Partnerships 12

Derma Sciences Plans To Enter Into Agreement For DSC127 12

Licensing Agreements 13

Derma Sciences Enters Into Licensing Agreement With BioD For Amniotic Membrane Wound Care Products 13

Equity Offering 14

Derma Sciences Raises USD2.3 Million in Private Placement of Shares 14

Derma Sciences Completes Public Offering Of Shares For USD86.3 Million 15

Derma Sciences Completes Public Offering Of Shares For USD36 Million 16

Derma Sciences Completes Private Placement Of Common Stock For USD20 Million 17

Derma Sciences Completes Private Placement For USD29 Million 19

Asset Transactions 21

Dukal Acquires First Aid Division from Derma Sciences for USD12.4 Million 21

Acquisition 22

Integra LifeSciences to Acquire Derma Sciences in Tender Offer 22

Derma Sciences Acquires BioD 24

Derma Sciences Acquires 7.3% Stake In Comvita For USD7 Million 25

Derma Sciences Inc-Key Competitors 27

Key Employees 28

Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

Financial Announcements 30

Nov 10, 2016: Derma Sciences Reports 2016 Third Quarter Financial Results 30

Aug 09, 2016: Derma Sciences Reports 2016 Second Quarter Financial Results 32

May 11, 2016: Derma Sciences Reports 2016 First Quarter Financial Results 34

Mar 16, 2016: Derma Sciences Reports 2015 Fourth Quarter and Full Year Financial Results 36

Jan 07, 2016: Derma Sciences Provides 2015 Preliminary Net Sales and Introduces 2016 Financial Guidance 38

Corporate Communications 39

Aug 18, 2016: Derma Sciences Names Russell Olsen President of Advanced Wound Care 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Derma Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Derma Sciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Derma Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Derma Sciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Derma Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Derma Sciences Acquires MEDIHONEY from Comvita 11

Derma Sciences Plans To Enter Into Agreement For DSC127 12

Derma Sciences Enters Into Licensing Agreement With BioD For Amniotic Membrane Wound Care Products 13

Derma Sciences Raises USD2.3 Million in Private Placement of Shares 14

Derma Sciences Completes Public Offering Of Shares For USD86.3 Million 15

Derma Sciences Completes Public Offering Of Shares For USD36 Million 16

Derma Sciences Completes Private Placement Of Common Stock For USD20 Million 17

Derma Sciences Completes Private Placement For USD29 Million 19

Dukal Acquires First Aid Division from Derma Sciences for USD12.4 Million 21

Integra LifeSciences to Acquire Derma Sciences in Tender Offer 22

Derma Sciences Acquires BioD 24

Derma Sciences Acquires 7.3% Stake In Comvita For USD7 Million 25

Derma Sciences Inc, Key Competitors 27

Derma Sciences Inc, Key Employees 28

Derma Sciences Inc, Subsidiaries 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Derma Sciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Derma Sciences Inc (Derma Sciences) is a medical devices company. It focuses on advanced wound care and traditional wound care. Its advanced wound care product portfolio includes dermagran, silverseal, alginate dressing, aquasite hydrogel, primacol hydrocolloid, hydrocell foam and primaderm wound cleanser. The company's traditional wound care products include sponges; wound dressings; packing; island and barrier border gauze; non-adherent impregnated; conforming bandages; elastic net dressings; compression bandages; protective products; tapes and laparotomy sponges. It offers solutions to acute care, extended care, home health care, wound and burn care clinics and physician offices. Derma Science markets its products through direct sales force in the US and Canada. In foreign markets, its products are marketed through various licensing and distribution agreements. It has offices, manufacturing and distribution facilities in Missouri and Texas in the US, Canada, the UK and China. Derma Sciences is headquartered in Princeton, New Jersey, the US.

Derma Sciences Inc (DSCI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Derma Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Derma Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Derma Sciences Acquires MEDIHONEY from Comvita 11

Partnerships 12

Derma Sciences Plans To Enter Into Agreement For DSC127 12

Licensing Agreements 13

Derma Sciences Enters Into Licensing Agreement With BioD For Amniotic Membrane Wound Care Products 13

Equity Offering 14

Derma Sciences Raises USD2.3 Million in Private Placement of Shares 14

Derma Sciences Completes Public Offering Of Shares For USD86.3 Million 15

Derma Sciences Completes Public Offering Of Shares For USD36 Million 16

Derma Sciences Completes Private Placement Of Common Stock For USD20 Million 17

Derma Sciences Completes Private Placement For USD29 Million 19

Asset Transactions 21

Dukal Acquires First Aid Division from Derma Sciences for USD12.4 Million 21

Acquisition 22

Integra LifeSciences to Acquire Derma Sciences in Tender Offer 22

Derma Sciences Acquires BioD 24

Derma Sciences Acquires 7.3% Stake In Comvita For USD7 Million 25

Derma Sciences Inc-Key Competitors 27

Key Employees 28

Locations And Subsidiaries 29

Head Office 29

Other Locations & Subsidiaries 29

Recent Developments 30

Financial Announcements 30

Nov 10, 2016: Derma Sciences Reports 2016 Third Quarter Financial Results 30

Aug 09, 2016: Derma Sciences Reports 2016 Second Quarter Financial Results 32

May 11, 2016: Derma Sciences Reports 2016 First Quarter Financial Results 34

Mar 16, 2016: Derma Sciences Reports 2015 Fourth Quarter and Full Year Financial Results 36

Jan 07, 2016: Derma Sciences Provides 2015 Preliminary Net Sales and Introduces 2016 Financial Guidance 38

Corporate Communications 39

Aug 18, 2016: Derma Sciences Names Russell Olsen President of Advanced Wound Care 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Derma Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Derma Sciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Derma Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Derma Sciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Derma Sciences Inc, Medical Devices Deals, 2011 to YTD 2017 9

Derma Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Derma Sciences Acquires MEDIHONEY from Comvita 11

Derma Sciences Plans To Enter Into Agreement For DSC127 12

Derma Sciences Enters Into Licensing Agreement With BioD For Amniotic Membrane Wound Care Products 13

Derma Sciences Raises USD2.3 Million in Private Placement of Shares 14

Derma Sciences Completes Public Offering Of Shares For USD86.3 Million 15

Derma Sciences Completes Public Offering Of Shares For USD36 Million 16

Derma Sciences Completes Private Placement Of Common Stock For USD20 Million 17

Derma Sciences Completes Private Placement For USD29 Million 19

Dukal Acquires First Aid Division from Derma Sciences for USD12.4 Million 21

Integra LifeSciences to Acquire Derma Sciences in Tender Offer 22

Derma Sciences Acquires BioD 24

Derma Sciences Acquires 7.3% Stake In Comvita For USD7 Million 25

Derma Sciences Inc, Key Competitors 27

Derma Sciences Inc, Key Employees 28

Derma Sciences Inc, Subsidiaries 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Derma Sciences Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.